Article History
Received: 3 March 2020
Accepted: 13 April 2020
First Online: 27 April 2020
Ethics approval and consent to participate
: Our trial was approved by the ethics committee and institutional review board at the South Egypt Cancer Institute under the number of SECI-IRB-IORG0006563: No: 407 on 27 December 2017. The committee that approved the research confirmed that all research was performed in accordance with relevant guidelines/regulations. The informed written consent was obtained from all participants and/or their legal guardians. The drugs were supplied by governmental and health insurance at the location of the study.
: Oral consent for publication was obtained from patients participating in this study.
: The authors declare that they have no competing interests.